Moderna Posts 38-Cent Profit, Beats Estimates and Lifts 2026 Outlook
Moderna beat estimates with $1.31 billion in Q3 revenue and a 38-cent profit, raising 2026 growth guidance to 15-25% as new vaccines gain traction.
Topic
Outlook
Topic
Topic
Topic
Moderna beat estimates with $1.31 billion in Q3 revenue and a 38-cent profit, raising 2026 growth guidance to 15-25% as new vaccines gain traction.